BeOne Medicines ONC
NASDAQ ONC
$358.85 -3.83 (-1.06%)
As of: Sep 4, 2026 · 2:24 PM EDT

BeOne Medicines (ONC) Assets (QoQ) (2016 - 2026)

Analysis

BeOne Medicines (ONC) Assets (QoQ) (2016 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn -
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn
10 Incyte 25.61 Bn 21.07 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.27%
Mar 31, 2026 4.46%
Dec 31, 2025 7.28%
Sep 30, 2025 21.18%
Jun 30, 2025 7.82%
Mar 31, 2025 -1.34%
Dec 31, 2024 1.54%
Sep 30, 2024 2.08%
Jun 30, 2024 0.79%
Mar 31, 2024 -2.37%
Dec 31, 2023 5.08%
Sep 30, 2023 -3.56%
Jun 30, 2023 -3.83%
Mar 31, 2023 -6.62%
Dec 31, 2022 -5.15%
Sep 30, 2022 -8.84%
Jun 30, 2022 -8.02%
Mar 31, 2022 -6.02%
Dec 31, 2021 61.46%
Sep 30, 2021 -4.30%